International Space Station experiments reveal risks for future human space flights

The team published their findings in the journal Heliyon on August 18, 2022.

In their study, the team performed a direct quantitative measurement of the biological effect of space radiation by launching frozen mouse embryonic stem cells from the ground to the International Space Station, exposing them to space radiation for over four years, and quantifying the biological effect by examining chromosome aberrations. Their experiment results show, for the first time, that the actual biological effect of space radiation is in close agreement with earlier predictions based on the physical measurement of space radiation.

Ordinary people are now able to travel in space, and the possibility of long-term manned flights to deep space, such as to the Moon and Mars, is increasing. Yet space radiation remains a limiting factor for manned exploration. Scientists have been conducting intensive studies to measure physical doses of space radiation to better understand its effect on the human body. However, since most of the studies until now were conducted on the ground, not in space, the results suffered from uncertainties, given that space radiation consists of many kinds of particles with different energies, and astronauts are continuously irradiated with low-dose rates. The actual space environment cannot be precisely reproduced on the ground.

"Our study aims to address the shortcomings of previous ground-based experiments by performing a direct quantitative measurement of the biological effect of space radiation on the International Space Station and comparing this real biological effect with physical estimates in the ground-based experiments," said Takashi Morita, a professor at the Graduate School of Medicine, Osaka Metropolitan University. "The findings contribute to reducing uncertainties in risk assessments of human space flights."

The team prepared about 1,500 cryotubes containing highly radio-sensitized mouse embryonic stem cells and sent them to space. Their study was complex in its scope, with seven years of work before launch, four years of work after launch, and five years for analysis. "It was difficult to prepare the experiment and to interpret the results, but we successfully obtained quantitative results related to space radiation, meeting our original objective," said Professor Morita.

Looking ahead, the researchers hope to take their studies a step further. "For future work, we are considering using human embryonic stem cells rather than mouse embryonic stem cells given that the human cells are much better suited for human risk assessment, and it is easier to analyze chromosome aberrations," said Professor Morita. Future studies might also include launching individual mice or other experimental animals to analyze their chromosome aberrations in space. "Such experiments in deep space can further contribute to reducing uncertainties in risk assessments of prolonged human journeys and stays in space," concluded Professor Morita.

The research team includes Kayo Yoshida, Akane Kizu, Kohei Kitada, and Takashi Morita, from Osaka Metropolitan University; Megumi Hada and Premkumar Saganti, from Prairie View A&M University; Kiyomi Eguchi-Kasai and Toshiaki Kokubo, from the National Institute of Quantum Science and Technology; Takeshi Teramura, from Kindai University; Sachiko Yano and Aiko Nagamatsu, from the Japan Aerospace Exploration Agency (JAXA); Hiromi Hashizume Suzuki, from Japan Space Forum (JSF); Hitomi Watanabe and Gen Kondoh, from Kyoto University; and Francis A. Cucinotta, from the University of Nevada.

JAXA, JSF, and the Ministry of Education, Culture, Sports, Science and Technology of Japan funded this research.